Patient leaflet - Meropenem 1 g powder for solution for injection or infusion
1. WHAT MEROPENEM IS AND WHAT IT IS USED FOR
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. It is preferable to avoid the use of meropenem during pregnancy. Your doctor will decide whether you should use Meropenem.
Meropenem contains the active substance meropenem and belongs to a group of medicines called carbapenem antibiotics. It works by killing bacteria, which can cause serious infections.
Meropenem is used to treat the following in adults and children aged 3 months and older:
It is important that you tell your doctor if you are breast-feeding or if you intend to breast-feed before receiving meropenem. Small amounts of this medicine may pass into the breast milk. Therefore, your doctor will decide whether you should use Meropenem while breast-feeding.
= Infection af fecting the lungs (pneumonia) = Lung and bronchial infections in patients suffering
from cystic fibrosis
= Complicated urinary tract infections
Driving and using machines
= Complicated infections in the abdomen = Infections that you can catch during or after the
No studies on the effect on the ability to drive and use machines have been performed. Meropenem has been associated with headache and tingling or pricking skin (paraesthesia). Any of these side effects could affect your ability to drive or operate machines.
delivery
= Complicated skin and soft tissues infections = Acute bacterial infection of the brain (meningitis) Meropenem may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
Meropenem may cause involuntary muscle movements which may cause the person's body to shake rapidly and uncontrollably (convulsions). This is usually accompanied with a loss of consciousness. Do not drive or use machines if you experience this side effect Meropenem contains sodium
Meropenem may be used to treat bacterial infection of the blood which might be associated with a type of infection mentioned above.
Meropenem 1 g: This medicine contains 90 mg sodium (main component of cooking/table salt) in each 1 g dose. This is equivalent to 4.5% of the recommended maximum daily dietary intake of sodium for an adult. If you have a condition which requires you to monitor your sodium intake please inform your doctor, pharmacist or nurse.
2. WHAT YOU NEED TO KNOW BEFORE YOU USE MEROPENEM
Do not use Meropenem if:
= you are allergic (hypersensitive) to meropenem or any of the other ingredients of Meropenem (listed in
3. HOW TO USE MEROPENEM
= you are allergic (hypersensitive) to other antibiotics such as penicillins, cephalosporins, or carbapenems as you may also be allergic to meropenem. Warnings and precautions
Always use this medicine exactly as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure. Use in adults
Talk to your doctor, pharmacist or nurse before using Meropenem if:
= The dose depends on the type of infection that you
= you have health problems, such as liver or kidney
have, where the infection is in the body and how serious the infection is. Your doctor will decide on the dose that you need.
problems.
= you have had severe diarrhoea after taking other antibiotics.
= The dose for adults is usually between 500 mg
= Liver problems
(milligrams) and 2 g (gram). You will usually receive a dose every 8 hours. However you may receive a dose less often if your kidneys do not work very well. Use in children and adolescents
If you notice yellowing of the skin and eyes, itchy skin, dark-coloured urine or light-coloured stool tell your doctor. This may be a sign of liver problems which your doctor needs to check.
Version: 03
Perforation for Tearing 540 mm
540 mm
years of age is decided using the age and weight of the child. The usual dose is between 10 mg and 40 mg of Meropenem for each kilogram (kg) that the child weighs. A dose is usually given every 8 hours. Children who weigh over 50 kg will be given an adult dose. How to use Meropenem
The following information is intended for medical or healthcare professionals only:
Instructions for giving Meropenem to yourself or someone else at home
Some patients, parents and carers are trained to give Meropenem at home.
= Meropenem will be given to you as an injection or
infusion into a large vein.
= Your doctor or nurse will normally give Meropenem to you.
Warning - You should only give this medicine to yourself or someone else at home after a doctor or nurse has trained you.
How to prepare this medicine
= However, some patients, parents and carers are trained to give Meropenem at home. Instructions for doing this are provided in this leaflet (in the section called ‘Instructions for giving Meropenem to yourself or someone else at home'). Always use Meropenem exactly as your doctor has told you. You should check with your doctor if you are not sure. = Your injection should not be mixed with or added to
solutions that contain other medicines.
= The injection may take about 5 minutes or between 15 and 30 minutes. Your doctor will tell you how to give Meropenem .
= You should normally have your injections at the same times each day.
If you use more Meropenem than you should
- The medicine must be mixed with another liquid (the diluent). Your doctor will tell you how much of the diluent to use.
- Use the medicine straight after preparing it. Do not freeze it.
- Wash your hands and dry them very well. Prepare a clean working area.
- Remove the Meropenem bottle (vial) from the packaging. Check the vial and the expiry date. Check that the vial is intact and has not been damaged.
Remove the coloured cap and clean the grey rubber stopper with an alcohol wipe. Allow the rubber stopper to dry.
- Connect a new sterile needle to a new sterile syringe, without touching the ends.
If you accidentally use more than your prescribed dose, contact your doctor or nearest hospital straight away. If you forget to use Meropenem
If you miss an injection, you should have it as soon as possible. However, if it is almost time for your next injection, skip the missed injection. Do not have a double dose (two injections at the same time) to make up for a forgotten dose.
If you stop using Meropenem
Do not stop having Meropenem until your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
4. POSSIBLE SIDE EFFECTS
- 5. Draw up the recommended amount of sterile 'Water for Injections' into the syringe. The amount of liquid that you need is shown in the table below:
| Dose of Meropenem | Amount of ‘Water for Injections’ needed for dilution |
| 1 g (gram) | 20 ml |
| 1.5 g | 30 ml |
| 2 g | 40 ml |
Please note: If your prescribed dose of Meropenem is more than 1 g, you will need to use more than 1 vial of Meropenem. You can then draw the liquid in the vials into the one syringe.
- 6. Put the needle of the syringe through the centre of the grey rubber stopper and inject the recommended amount of Water for Injections into the vial or vials of Meropenem.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Severe allergic reactions
If you have any of these signs and symptoms, tell your doctor or nurse straight away. You may need urgent medical treatment. The signs and symptoms may include a sudden onset of:
= Severe rash, itching or hives on the skin. = Swelling of the face, lips, tongue or other parts of the
body.
= Shortness of breath, wheezing or trouble breathing. = Serious skin reactions which include
- 7. Remove the needle from the vial and shake the vial well for about 5 seconds, or until all the powder has dissolved. Clean the grey rubber stopper once more with a new alcohol wipe and allow the rubber stopper to dry.
- 8. With the plunger of the syringe pushed fully into the syringe, put the needle back through the grey rubber stopper. You must then hold both the syringe and the vial and turn the vial upside down.
- 9. Keeping the end of the needle in the liquid, pull back the plunger and draw all the liquid in the vial into the syringe.
- 10. Remove the needle and syringe from the vial and throw the empty vial away in a safe place.
o Serious hypersensitivity reactions involving fever, skin rash, and changes in the blood tests that check how the liver is working (increased levels of liver enzymes) and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes. These may be signs of a multi- organ sensitivity disorder known as DRESS syndrome.
o Severe red scaly rash, skin bumps that contain pus, blisters or peeling of skin, which may be associated with a high fever and joint pains.
- 11. Hold the syringe upright, with the needle pointing upwards. Tap the syringe so that any bubbles in the liquid rise to the top of the syringe.
- 12. Remove any air in the syringe by gently pushing the plunger until all the air has gone.
- 13. If you are using Meropenem at home, dispose of any needles and infusion lines that you have used in an appropriate way. If your doctor decides to stop your treatment, dispose of any unused Meropenem in an appropriate way.
Giving the injection
o Severe skin rashes that can appear as reddish circular patches often with central blisters on the trunk, skin peeling, ulcers of mouth, throat, nose, genitals and eyes and can be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome) or a more severe form (toxic epidermal necrolysis).
Damage to red blood cells (not known)
The signs include:
You can either give this medicine through a short cannula or venflon, or through a port or central line. Giving Meropenem through a short cannula or venflon
- 1. Remove the needle from the syringe and throw the needle away carefully in your sharps bin.
- 2. Wipe the end of the short cannula or venflon with an alcohol wipe and allow it to dry. Open the cap on your cannula and connect the syringe.
= Being breathless when you do not expect it. = Red or brown urine.
If you notice any of the above, see a doctor straight away.
- 3. Slowly push the plunger of the syringe to give the antibiotic steadily over about 5 minutes.
- 4.
Once you have finished giving the antibiotic and the
syringe is empty, remove the syringe and use a flush as recommended by your doctor or nurse.
- 5. Close the cap of your cannula and carefully throw the syringe away in your sharps bin.
Giving Meropenem through a port or central line
- 1. Remove the cap on the port or line, clean the end of the line with an alcohol wipe and allow it to dry.
- 2. Connect the syringe and slowly push the plunger on the syringe to give the antibiotic steadily over about 5 minutes.
- 3. Once you have finished giving the antibiotic, remove the syringe and use a flush as recommended by your doctor or nurse.
- 4. Place a new clean cap on your central line and carefully throw the syringe away in your sharps bin. The following information is intended for healthcare professional only. For full prescribing information please refer to the SmPC.
Posology and method of administration
Posology
The tables below provide general recommendations for dosing.
The dose of meropenem administered and the duration of treatment should take into account the type of infection to be treated, including its severity, and the clinical response.
A dose of up to 2 g three times daily in adults and adolescents and a dose of up to 40 mg/kg three times daily in children may be particularly appropriate when treating some types of infections, such as infections due to less susceptible bacterial species (e.g. Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp.), or very severe infections. Additional considerations for dosing are needed when treating patients with renal insufficiency (see further below).
26-50 one unit dose every 12 hours 10-25 half of one unit dose every 12 hours <10 half of one unit dose every 24 hours Adults and Adolescents
Infection Dose to be administered every 8 hours Severe pneumonia including 500 mg or 1 g hospital and ventilator-associated pneumonia.
Broncho-pulmonary 2 g infections in cystic fibrosis
Complicated urinary tract 500 mg or 1 g infections
Complicated intra-abdominal 500 mg or 1 g infections
Intra- and post-partum 500 mg or 1 g infections
Complicated skin and soft 500 mg or 1 g tissue infections
Acute bacterial meningitis 2 g
Management of febrile 1 g neutropenic patients
Meropenem is usually given by intravenous infusion over approximately 15 to 30 minutes (see sections 6.2, 6.3 and 6.6).
Alternatively, doses up to 1 g can be given as an intravenous bolus injection over approximately 5 minutes. There are limited safety data available to support the administration of a 2 g dose in adults as an intravenous bolus injection.
Renal impairment
The dose for adults and adolescents should be adjusted when creatinine clearance is less than 51 ml/min, as shown below. There are limited data to support the administration of these dose adjustments for a unit dose of 2 g.
Creatinine Dose (based on Frequency clearance “unit” dose range of or
(ml/min) 500 mg or 1 g or 2 g, see table above)
Meropenem is cleared by haemodialysis and haemofiltration. The required dose should be administered after completion of the haemodialysis cycle.
There are no established dose recommendations for patients receiving peritoneal dialysis.
Hepatic impairment
No dose adjustment is necessary in patients with hepatic impairment (see section 4.4.).
Dose in elderly patients
No dose adjustment is required for the elderly with normal renal function or creatinine clearance values above 50 ml/min.
Paediatric population
Children under 3 months of age
The safety and efficacy of meropenem in children under 3 months of age have not been established and the optimal dose regimen has not been identified. However, limited pharmacokinetic data suggest that 20 mg/kg every 8 hours may be an appropriate regimen (see section 5.2).
Children from 3 months to 11 years of age and up to 50 kg body weight The recommended dose regimens are shown in the table below:
Infection Dose to be administered every 8 hours Severe pneumonia including 10 or 20 mg/kg hospital and ventilator
associated pneumonia
Broncho-pulmonary infections 40 mg/kg in cystic fibrosis
Complicated urinary tract 10 or 20 mg/kg infections
Complicated intra-abdominal 10 or 20 mg/kg infections
Complicated skin and 10 or 20 mg/kg soft tissue infections
Acute bacterial meningitis 40 mg/kg Management of febrile 20 mg/kg neutropenic patients
Children over 50 kg body weight
The adult dose should be administered.
There is no experience in children with renal impairment.
Method of administration
Meropenem is usually given by intravenous infusion over approximately 15 to 30 minutes (see sections 6.2, 6.3, and 6.6). Alternatively, meropenem doses of up to 20 mg/kg may be given as an intravenous bolus over approximately 5 minutes. There are limited safety data available to support the administration of a 40 mg/kg dose in children as an intravenous bolus injection. For instructions on reconstitution of the medicinal product before administration, see section 6.6. Incompatibilities
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6
Shelf life
2 years
After reconstitution:
Intravenous bolus injection administration
A solution for bolus injection is prepared by dissolving the drug product in water for injection to a final concentration of 50 mg/ml. Chemical and physical in-use stability for a prepared solution for bolus injection has been demonstrated for 3 hours at up to 25°C or 12 hours under refrigerated conditions (2-8°C). From a microbiological point of view, unless the method of opening/reconstitution/dilution precludes the risk of microbiological contamination, the product should be used immediately.
If not used immediately in-use storage times and conditions are the responsibility of the user. Intravenous infusion administration
Perforation
for Tearing
A solution for infusion is prepared by dissolving the drug product in either 0.9% sodium chloride solution for infusion or 5% dextrose solution for infusion to a final concentration of 1 to 20 mg/ml. Chemical and physical in-use stability for a prepared solution for infusion using 0.9% sodium chloride solution has been demonstrated for 3 hours at up to 25°C or 6 hours under refrigerated conditions (2-8°C).
From a microbiological point of view, unless the method of opening/ reconstitution/dilution precludes the risk of microbiological contamination, the product should be used immediately.
If not used immediately in-use storage times and conditions are the responsibility of the user. Reconstituted solution of the product in 5% dextrose solution should be used immediately. The constituted solutions should not be frozen.
Special precautions for storage
The medicinal product does not require any special storage condition.
Do not freeze the reconstituted solution.
For storage conditions after reconstitution of the medicinal product, see section 6.3.
Special precautions for disposal and other handling
Injection
Meropenem to be used for bolus intravenous injection should be constituted with sterile water for injection. Infusion
For intravenous infusion meropenem vials may be directly constituted with 0.9% sodium chloride or 5% dextrose solutions for infusion.
Each vial is for single use only.
Standard aseptic techniques should be used for solution preparation and administration.
The solution should be shaken before use.
Any unused product or waste material should be disposed of in accordance with local requirements.
Muscle breakdown
* Unexplained muscle pain, tenderness or weakness, and/or dark coloured urine.
If you notice any of the above, see a doctor straight away.
Other possible side effects:
Common (may affect up to 1 in 10 people)
= Abdominal (stomach) pain.
= Feeling sick (nausea).
= Being sick (vomiting).
= Diarrhoea.
= Headache.
= Skin rash, itchy skin.
= Pain and inflammation.
= Increased numbers of platelets in your blood (shown in a blood test).
= Changes in blood tests, including tests that show how well your liver is working.
Uncommon (may affect up to 1 in 100 people)
= Changes in your blood. These include reduced
numbers of platelets (which may make you bruise more easily), increased numbers of some white blood cells, decreased numbers of other white cells and increased amounts of a substance called ‘bilirubin'. Your doctor may do blood tests from time to time.
= Changes in blood tests, including tests that show how well your kidney is working.
= A tingling feeling (pins and needles).
= Infections of the mouth or the vagina that are caused
by a fungus (thrush).
= Inflammation of the bowel with diarrhoea. = Sore veins where Meropenem is injected. = Other changes in your blood. The symptoms include frequent infections, high temperature and sore throat. Your doctor may do blood tests from time to time
= Reduced levels of potassium in your blood (which can cause weakness, muscle cramps, tingling and heart rhythm disturbances).
= Liver problems. Yellowing of the skin and eyes, itchy skin, dark-coloured urine or light-coloured stool. If you notice these signs or symptoms, see a doctor straight away.
Rare (may affect up to 1 in 1,000 people)
= Fits (convulsions).
= Acute disorientation and confusion (delirium). Sudden chest pain, which may be a sign of a potentially serious allergic reaction called Kounis syndrome has been noted with other medicines of the same type. If this happens talk to a doctor or nurse immediately.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE MEROPENEM
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the container. The expiry date refers to the last day of that month.
The medicinal product does not require any special storage condition.
Injection
After reconstitution: The reconstituted solutions for intravenous injection should be used immediately. The time interval between the beginning of reconstitution
and the end of intravenous injection should not exceed: = 3 hours when stored at up to 25°C;
= 12 hours when stored under refrigerated conditions (2-8°C).
Infusion
After reconstitution: The reconstituted solutions for intravenous infusion should be used immediately. The time interval between the beginning of reconstitution and the end of intravenous infusion should not exceed: = 3 hours when stored at up to 25°C when Meropenem is dissolved in sodium chloride; = 6 hours when stored under refrigerated conditions (2-8°C) when Meropenem is dissolved in sodium chloride;
= when Meropenem is dissolved in dextrose the solution should be used immediately.
From a microbiological point of view, unless the method of opening/reconstitution/dilution precludes the risk of microbiological contamination, the product should be used immediately.
If not used immediately in-use storage times and conditions are the responsibility of the user. Do not freeze the reconstituted solution.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Meropenem contains
The active substance is meropenem trihydrate equivalent to 1 g anhydrous meropenem. The other ingredient is anhydrous sodium carbonate. . What Meropenem looks like and contents of the pack
= Meropenem is a white to light yellow powder for solution for injection or infusion in a vial. Pack sizes of 1 or 10 vials
Marketing Authorisation Holder and Manufacturer Strides Pharma UK Ltd
Unit 4, The Metro Centre Dwight Road
Watford, WD18 9SS, United Kingdom
Advice/medical education
Antibiotics are used to treat infections caused by bacteria. They have no effect against infections caused by viruses.
Sometimes an infection caused by bacteria does not respond to a course of an antibiotic. One of the commonest reasons for this to occur is because the bacteria causing the infection are resistant to the antibiotic that is being taken. This means that they can survive and even multiply despite the antibiotic. Bacteria can become resistant to antibiotics for many reasons. Using antibiotics carefully can help to reduce the chance of bacteria becoming resistant to them. When your doctor prescribes a course of an antibiotic it is intended to treat only your current illness. Paying attention to the following advice will help prevent the emergence of resistant bacteria that could stop the antibiotic working.
- 1. It is very important that you take the antibiotic at the right dose, at the right times and for the right number of days. Read the instructions on the label and if you do not understand anything ask your doctor or pharmacist to explain.
- 2. You should not take an antibiotic unless it has been prescribed specifically for you and you should use it only to treat the infection for which it was prescribed.
- 3. You should not take antibiotics that have been prescribed for other people even if they had an infection that was similar to yours.
- 4.
You should not give antibiotics that were prescribed for you to other people.
- 5. If you have any antibiotic left over when you have taken the course as directed by your doctor you should take the remainder to a pharmacy for appropriate disposal.
This leaflet was last revised in 11/2025
Back Side
